Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer.
Saved in:
| Title: | Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer. |
|---|---|
| Authors: | Fu R; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Wang Y; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Rehman I; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.; Department of Biotechnology, The Neotia University, Sarisha, West Bengal, 743368, India., Bedford E; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Sharif S; Department of Pharmacological and Pharmaceutical Sciences, The University of Houston College of Pharmacy, Houston, TX, 77204, USA., Nguyen ND; Texas A&M Health Center for Translational Cancer Research, Houston, TX, 77030, USA., Powell RT; Texas A&M Health Center for Translational Cancer Research, Houston, TX, 77030, USA., Adams A; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Liu W; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Wang S; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., He W; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Lu Y; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Liu B; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Shah PA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Ahnert JR; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Chen T; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Peng W; Department of Biology and Biochemistry, University of Houston, Houston, TX, 77004, USA., Stephan CC; Texas A&M Health Center for Translational Cancer Research, Houston, TX, 77030, USA., Liu X; Department of Pharmacological and Pharmaceutical Sciences, The University of Houston College of Pharmacy, Houston, TX, 77204, USA., Bedford MT; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA., Xu H; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2026 Apr 21. Date of Electronic Publication: 2026 Apr 21. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42079286 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fu+R%22">Fu R</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.<br /><searchLink fieldCode="AU" term="%22Rehman+I%22">Rehman I</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.; Department of Biotechnology, The Neotia University, Sarisha, West Bengal, 743368, India.<br /><searchLink fieldCode="AU" term="%22Bedford+E%22">Bedford E</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.<br /><searchLink fieldCode="AU" term="%22Sharif+S%22">Sharif S</searchLink>; Department of Pharmacological and Pharmaceutical Sciences, The University of Houston College of Pharmacy, Houston, TX, 77204, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+ND%22">Nguyen ND</searchLink>; Texas A&M Health Center for Translational Cancer Research, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Powell+RT%22">Powell RT</searchLink>; Texas A&M Health Center for Translational Cancer Research, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Adams+A%22">Adams A</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.<br /><searchLink fieldCode="AU" term="%22Liu+W%22">Liu W</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.<br /><searchLink fieldCode="AU" term="%22Wang+S%22">Wang S</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.<br /><searchLink fieldCode="AU" term="%22He+W%22">He W</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.<br /><searchLink fieldCode="AU" term="%22Lu+Y%22">Lu Y</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.<br /><searchLink fieldCode="AU" term="%22Liu+B%22">Liu B</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.<br /><searchLink fieldCode="AU" term="%22Shah+PA%22">Shah PA</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Ahnert+JR%22">Ahnert JR</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Chen+T%22">Chen T</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.<br /><searchLink fieldCode="AU" term="%22Peng+W%22">Peng W</searchLink>; Department of Biology and Biochemistry, University of Houston, Houston, TX, 77004, USA.<br /><searchLink fieldCode="AU" term="%22Stephan+CC%22">Stephan CC</searchLink>; Texas A&M Health Center for Translational Cancer Research, Houston, TX, 77030, USA.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Department of Pharmacological and Pharmaceutical Sciences, The University of Houston College of Pharmacy, Houston, TX, 77204, USA.<br /><searchLink fieldCode="AU" term="%22Bedford+MT%22">Bedford MT</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.<br /><searchLink fieldCode="AU" term="%22Xu+H%22">Xu H</searchLink>; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2026 Apr 21. <i>Date of Electronic Publication: </i>2026 Apr 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Preprint – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42079286 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.64898/2026.04.16.719008 Languages: – Code: eng Text: English Titles: – TitleFull: Acquired resistance to the PRMT5 inhibitor confers collateral sensitivity to MEK inhibition in MTAP-null non-small cell lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fu R – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Rehman I – PersonEntity: Name: NameFull: Bedford E – PersonEntity: Name: NameFull: Sharif S – PersonEntity: Name: NameFull: Nguyen ND – PersonEntity: Name: NameFull: Powell RT – PersonEntity: Name: NameFull: Adams A – PersonEntity: Name: NameFull: Liu W – PersonEntity: Name: NameFull: Wang S – PersonEntity: Name: NameFull: He W – PersonEntity: Name: NameFull: Lu Y – PersonEntity: Name: NameFull: Liu B – PersonEntity: Name: NameFull: Shah PA – PersonEntity: Name: NameFull: Ahnert JR – PersonEntity: Name: NameFull: Chen T – PersonEntity: Name: NameFull: Peng W – PersonEntity: Name: NameFull: Stephan CC – PersonEntity: Name: NameFull: Liu X – PersonEntity: Name: NameFull: Bedford MT – PersonEntity: Name: NameFull: Xu H IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 04 Text: 2026 Apr 21 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |